iCAD, Inc. (ICAD)
NASDAQ: ICAD · Real-Time Price · USD
3.990
+0.070 (1.79%)
At close: May 16, 2025, 4:00 PM
3.890
-0.100 (-2.51%)
After-hours: May 16, 2025, 6:53 PM EDT
iCAD, Inc. Employees
iCAD, Inc. had 66 employees as of December 31, 2024. The number of employees decreased by 3 or -4.35% compared to the previous year.
Employees
66
Change (1Y)
-3
Growth (1Y)
-4.35%
Revenue / Employee
$295,879
Profits / Employee
-$79,197
Market Cap
108.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ICAD News
- 4 days ago - iCAD Reports Financial Results for First Quarter Ended March 31, 2025 - GlobeNewsWire
- 4 weeks ago - ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD - Business Wire
- 5 weeks ago - iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer - GlobeNewsWire
- 2 months ago - iCAD, Inc. (ICAD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024 - GlobeNewsWire
- 2 months ago - iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America - GlobeNewsWire
- 2 months ago - Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025 - GlobeNewsWire
- 3 months ago - iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025 - GlobeNewsWire